Crucial approaches to diagnostics and anaemia treatment in pregnant women with heart failure at the extragenital pathology clinic

Authors

  • Yuliya Vladimirovna Davydova Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine, Ukraine
  • K. G. Apresova Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine, Ukraine
  • А. А. Ogorodnik Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine, Ukraine
  • А. N. Mokrik Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine, Ukraine
  • A. Yu. Limanskaya Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine, Ukraine
  • L. P. Butenko Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine, Ukraine
  • A. V. Pashynnyi Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine, Ukraine

DOI:

https://doi.org/10.18370/2309-4117.2013.14.32-35

Keywords:

aneamia, pregnancy, heart failure, diagnostics, treatment, Maltofer

Abstract

According to modern concepts, aneamia can be a cause of chronic heart failure (CHF) and its result. According to diff erent sources aneamia of chronic disease is the most frequent among patients with the CHF and it is observed in cases of over than 50% patients.
There can be no doubt that combination of aneamia and heart failurein pregnant aggravates the outcomes, increases a risk of severe «cardiac events», and perinatal complications. Overlap of aneamia and heart failure can cause a high risk of fetus growth inhibition, prematurity, a low-birth-weight infant.
According to the foregoing we proved the following examination algorithm for pregnant women with congenital heart diseases of various ethiology and NYHA II–III heart failure.
1. Clinical blood test (reduction in a haemoglobin level below the standard by trimesters – treatment of aneamia). If the heamoglobin level remains within normal limits for a certain trimester but there have been observed signs of apparent heart failure, disorders of life qualities (dyspnea, undue fatiguability, cardiac pains), then the algorithm provides the following examination:
2. C-reactive protein (avoidance of the active phase of the infl ammatory process).
3. Ferritin.
4. Transferrin saturation.
5. Brain natriuretic peptide.

Author Biographies

Yuliya Vladimirovna Davydova, Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine

Institute of Pediatrics, Obstetrics, and Gynecology of NAMS of Ukraine

K. G. Apresova, Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine

MD, chief researcher, Obstetrical Problems of Extragenital Pathology Department

А. А. Ogorodnik, Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine

PhD, junior researcher, Obstetrical Problems of Extragenital Pathology Department

А. N. Mokrik, Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine

PhD, researcher, Obstetrical Problems of Extragenital Pathology Department

A. Yu. Limanskaya, Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine

PhD, senior scientist, Obstetrical Problems of Extragenital Pathology Department

References

  1. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). // Circulation. 2001; 103: 2055–2059.
  2. Ezekowitz JA, McAlister FA, Armstrong PW Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. // Circulation. 2003; 107: 223–225.
  3. He SW, Wang LX The impact of anemia on the prognosis of chronic heart failure: a meta-analysis and systemic review. // Congest Heart Fail 2009; 15: 123.
  4. Ganzevoort W Plasma volume and blood pressure regulation in hypertensive pregnancy // J. Hypertens. – 2004. – Vol. 22. – P. 1235-1242.
  5. Gei AF Cardiac disease and pregnancy/ A.F. Gei, G.D.Hankins // Obstet. Gynecol. Clin.North. Am. – 2001. – Vol. 28. – P. 465 – 512.
  6. Gelson E Cardiac disease in pregnancy: congenital heart disease/ E. Gelson, M. Jhonson,M. Gatzolius et al. // The Obst. and Gynaec. 2007. N 9. P. 15–20.
  7. Globits S Atrial natriuretic peptide release is more dependent on atrial fi lling volume than on filling pressure in chronic congestive heart failure/ S. Globits, H. Frank, B. Pacher et al. // Am. Heart J. – 1998. – N 135. – P. 592–597.
  8. Silverberg DS, Wexler D, Palazzuoli A et al. The anemia of heart failure. // ActaHaematol 2009; 122: 109.
  9. Shah R, Agarwal AK Anemia associated with chronic heart failure: current concepts. // ClinInterv Aging 2013; 8: 111.
  10. Szachniewicz J, Petruk-Kowalczyk J, Majda J, Kaczmarek A, Reczuch K, Kalra PR, Piepoli MF, Anker SD, Banasiak W, Ponikowski P Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol. 2003; 90: 303–308.
  11. Tanner H, Moschovitis G, Kuster GM, Hullin R, Pfi iff ner D, Hess OM, Mohacsi P The prevalence of anemia in chronic heart failure. // Int J Cardiol.2002; 86: 115–121.
  12. Tang Yi-Da, Katz S Anemia in chronic heart failure. Prevalence, Etiology, Clinical correlates and Treatment options. // Circulation. 2006; 113: 2454–2461.

Downloads

Published

2013-11-12

How to Cite

Davydova, Y. V., Apresova, K. G., Ogorodnik А. А., Mokrik А. N., Limanskaya, A. Y., Butenko, L. P., & Pashynnyi, A. V. (2013). Crucial approaches to diagnostics and anaemia treatment in pregnant women with heart failure at the extragenital pathology clinic. REPRODUCTIVE ENDOCRINOLOGY, (14), 32–35. https://doi.org/10.18370/2309-4117.2013.14.32-35

Issue

No. 14 (2013)

Section

Obstetrics

License

Copyright (c) 2014 Yuliya Vladimirovna Davydova, K. G. Apresova, А. А. Ogorodnik, А. N. Mokrik, A. Yu. Limanskaya, L. P. Butenko, A. V. Pashynnyi

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.